Nurr1 receptor modulators (X-Ceptor Therapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNurr1 receptor modulators (X-Ceptor Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor subfamily 4 group A member 2 modulators
TargetsNuclear receptor subfamily 4 group A member 2
Therapy Area/IndicationsParkinson DiseaseLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesX-Ceptor Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesX-Ceptor Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsParkinson DiseaseLeukemia

Other Information

ATC CodeN/A
Related LinksN/A